Cytogenetic Evaluation in Hematological Malignancies
ZEISS Axio Imager Z2 with MetaSystems
- 00 years
- 00 months
- 00 days
- 00 hours
- 00 minutes
- 00 seconds
ZEISS Axio Imager Z2 with MetaSystems
Artificial Intelligence based IKAROS & FISH System
Blood cancer, also called hematological cancer, occurs when abnormal cells in the blood grow out of control. Hematological malignancies are primary cancers of the blood and blood-forming organs (bone marrow and lymphoid tissues), which includes leukemia, lymphoma and myeloma.
Cytogenetics has become an essential part of diagnosis and management of the haematological malignancies. The presence of specific chromosomal and genetic alterations exclusively observed in malignant cells helps in diagnosis, risk stratification, treatment response and prognostic assessment.
Learn More About Cytogenetics
Webinar Highlights
- Understanding the cytogenetics of different types of haematological malignancies
- How cytogenetic evaluation is useful in diagnosis and prognostication
Webinar Schedule
Date: 19th December, 2023
Time: 11:30 AM - 12:30 PM IST
Dr. Dhanlaxmi Shetty, PhD, is a renowned expert in Cancer Cytogenetics, holding a leadership role at ACTREC-Tata Memorial Centre. With a Ph.D. in Applied Biology and postgraduate diplomas in Healthcare Management and Medico-Legal Systems, she's a recipient of the ICMR SRF and a Long-term ICMR-DHR International Fellow. Dr. Shetty is certified in Genetic Counseling, Clinical Laboratory Genetics, and Cytogenetics.
Her impactful career includes roles at renowned institutions like Inkus IVF Centre and Metropolis Healthcare. As an Executive Director at Igenetic Diagnostics, she contributed significantly to the field. Dr. Shetty is actively involved in academia, offering an Advanced Cytogenetic Training Course and contributing to the EQAS program. With over 50 publications and memberships in genetic societies, she's committed to advancing genetic research.
Register here for the webinar
Please fill out the form below